Modulation of NMDA receptor function by inhibition of d-amino acid oxidase in rodent brain

Neuropharmacology

Volumn 61, Issue 5-6, 2011, Pages 1001-1015

  Strick, Christine A ^a   Li, Cheryl ^a   Scott, Liam ^a   Harvey, Brian ^a   Hajós, Mihály ^a   Steyn, Stefanus J ^a   Piotrowski, Mary A ^a   James, Larry C ^a   Downs, James T ^a   Rago, Brian ^a   Becker, Stacey L ^a   El Kattan, Ayman ^a   Xu, Youfen ^a   Ganong, Alan H ^a   Tingley III, F David ^a   Ramirez, Andres D ^a   Seymour, Patricia A ^a   Guanowsky, Victor ^a   Majchrzak, Mark J ^a   Fox, Carol B ^a   Schmidt, Christopher J ^a   Duplantier, Allen J ^a   more..

^a PFIZER INC   (United States)

Author keywords

Cognition; d amino acid oxidase; d serine; NMDA receptor; Schizophrenia

Indexed keywords

2 [3 HYDROXYQUINOLIN 2(1H) ONE]; 4H FURO[3,2 B]PYRROLE 5 CARBOXYLIC ACID; CARBOXYLIC ACID DERIVATIVE; DEXTRO AMINO ACID OXIDASE; DEXTRO AMINO ACID OXIDASE INHIBITOR; DEXTRO SERINE; ENZYME INHIBITOR; MESCALINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; QUINOLINOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN FUNCTION; CEREBELLUM; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; ENZYME INHIBITION; FOREBRAIN; HIPPOCAMPUS THETA RHYTHM; IN VIVO STUDY; MALE; MOUSE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; RODENT; SCRATCHING; SYNAPSE;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CYCLIC GMP; D-AMINO-ACID OXIDASE; DRUG EVALUATION, PRECLINICAL; ELECTROENCEPHALOGRAPHY; HABITUATION, PSYCHOPHYSIOLOGIC; HARMALINE; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY, SHORT-TERM; MESCALINE; MICE; MINIATURE POSTSYNAPTIC POTENTIALS; MODELS, BIOLOGICAL; MODELS, CHEMICAL; MOLECULAR TARGETED THERAPY; MOTOR ACTIVITY; PRURITUS; PSYCHOMOTOR AGITATION; RATS; RATS, LONG-EVANS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SENSORY GATING; SERINE; SEROTONIN RECEPTOR AGONISTS;

EID: 80051785985     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.06.029     Document Type: Article

References (46)

1. T. Adage, A.C. Trillat, A. Quattropani, D. Perrin, L. Cavarec, J. Shaw, O. Guerassimenko, C. Giachetti, B. Greco, I. Chumakov, S. Halazy, A. Roach, and P. Zaratin In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties Eur. Neuropsychopharm. 18 2008 200 214
2. G.K. Aghajanian, and G.J. Marek Serotonin model of schizophrenia: emerging role of glutamate mechanisms Brain Res. Rev. 31 2000 302 312 (Pubitemid 30136185)
3. N.C. Allen, S. Bagade, M.B. McQueen, J.P.A. Ioannidis, F.K. Kavvoura, M.J. Khoury, R.E. Tanzi, and L. Bertram Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database Nat. Genet. 40 2008 827 834 (Pubitemid 351913655)
4. S.L. Almond, R.L. Fradley, E.J. Armstrong, R.B. Heavens, A.R. Rutter, R.J. Newman, C.S. Chiu, R. Konno, P.H. Hutson, and N.J. Brandon Behavioral and biochemical characterization of a mutant mouse strain lacking d-amino acid oxidase activity and its implications for schizophrenia Mol. Cell Neuroscience. 32 2006 324 334 (Pubitemid 44163228)
5. I. Bendikov, C. Nadri, S. Amar, R. Panizzutti, J. De Miranda, H. Wolosker, and G. Agam A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia Schizophr. Res. 90 2007 41 51 (Pubitemid 46177566)
6. P.W.J. Burnet, S.L. Eastwood, G.C. Bristow, B.R. Godlewska, P. Sikka, M. Walker, and P.J. Harrison d-amino acid oxidase activity and expression are increased in schizophrenia Mol. Psychiatry 13 2008 658 660 (Pubitemid 351861536)
7. G. Buzsáki Theta oscillations in the hippocampus Neuron 33 2002 325 340 (Pubitemid 34158839)
8. I. Chumakov, M. Blumenfield, and O. Guerassimenko Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia Proc. Natl. Acad. Sci. U. S. A. 99 2002 13675 13680 (Pubitemid 35215440)
9. A.J. Duplantier, S.L. Becker, M.J. Bohanon, K.A. Borzilleri, B.A. Chrunyk, J.T. Downs, L.-Y. Hu, A. El-Kattan, L.C. James, S. Liu, J. Lu, N. Maklad, M.N. Mansour, S. Mente, M.A. Piotrowski, S.M. Sakya, S. Sheehan, S.J. Steyn, C.A. Strick, V.A. Williams, and L. Zhang Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent d-amino acid oxidase (DAAO) inhibitors J. Med. Chem. 52 2009 3576 3585
10. D. Ferraris, B. Duvall, Y.-S. Ko, A.G. Thomas, C. Rojas, P. Majer, K. Hashimoto, and T. Tsukamoto Synthesis and biological evaluation of d-amino acid oxidase inhibitors J. Med. Chem. 51 2008 3357 3359 (Pubitemid 351874993)
11. V.N. Foltyn, I. Bendikov, J. De Miranda, R. Panizzutti, E. Dumin, M. Shleper, P. Li, M.D. Toney, E. Kartvelishvily, and H. Wolosker Serine racemase modulates intracellular d-serine levels through an α, β-elimination activity J. Biol. Chem. 280 2005 1754 1763
12. J. Gonzalez-Maeso, N.V. Weisstaub, M. Zhou, P. Chan, L. Ivic, R. Ang, A. Lira, M. Bradley-Moore, Y. Ge, Q. Zhou, S.C. Sealfon, and J.A. Gingrich Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior Neuron 53 2007 439 452 (Pubitemid 46161267)
13. M. Hajós, C.J. Siok, W.E. Hoffman, S. Li, and B. Kocsis Modulation of hippocampal theta oscillation by histamine H3 receptors J. Pharmacol. Exp. Ther. 324 2008 391 398 (Pubitemid 350294183)
14. K. Hamase, R. Konno, A. Morikawa, and K. Zaitsu Sensitive determination of d-amino acids in mammals and the effect of d-amino acid oxidase activity on their amounts Biol. Pharm. Bull. 28 2005 1578 1584 (Pubitemid 41324112)
15. A. Hashimoto, R. Konno, H. Yano, M. Yoshikawa, R. Tamaki, H. Matsumoto, and H. Kobayashi Mice lacking d-amino acid oxidase activity exhibit marked reduction of methamphetamine-induced stereotypy Eur. J. Pharmacol. 586 2008 221 225
16. A. Hashimoto, M. Yoshikawa, A. Niwa, and R. Konno Mice lacking d-amino acid oxidase activity display marked attenuation of stereotypy and ataxia induced by MK-801 Brain Res. 1033 2005 210 215 (Pubitemid 40193416)
17. K. Hashimoto, Y. Fujita, M. Horio, S. Kunitachi, M. Iyo, D. Ferraris, and T. Tsukamoto Co-Administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine Biol. Psychiatry 65 2009 1103 1106
18. K. Hashimoto, G. Engberg, E. Shimizu, C. Nordin, L.H. Lindstroem, and M. Iyo Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients Prog. Neuropsychopharmacol. Biol. Psychiatry 29 2005 767 769 (Pubitemid 40897791)
19. S.D. Hess, L.P. Daggett, C. Crona, C. Deal, C.-C. Lu, A. Urrutia, L. Chavez-Nopriega, S.B. Ellis, E.C. Johnson, and G. Velicelebi Cloning and functional characterization of human heteromeric N-methyl-d-aspartate receptors J. Pharmacol. Exp. Ther. 278 1996 808 816
20. M. Horio, Y. Fujita, T. Ishima, M. Iyo, D. Ferraris, T. Tsukamoto, and K. Hashimoto Effects of D-amino acid oxidase inhibitor on the extracellular D-alanine levels and the efficacy of D-alanine on dizocilpine-induced prepulse inhibition deficits in mice Open Clin. Chem. J 2 2009 16 21
21. U. Huresco-Levy, and D. Javitt Comparative effects of glycine and d-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis Schizophr. Res. 66 2004 89 96 (Pubitemid 38041106)
22. M.W. Jones, and M.A. Wilson Theta rhythms coordinate hippocampal- prefrontal interactions in a spatial memory task PLoS Biol. 3 2005 e402
23. J.C. Kalvass, and T.S. Maurer Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery Biopharm. Drug Dispos. 23 2002 327 338 (Pubitemid 36124162)
24. R. Kapoor, K.S.Y. Lim, A. Cheng, T. Garrick, and V. Kapoor Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1) Brain Res. 1106 2006 205 210 (Pubitemid 44177639)
25. R. Konno, and Y. Yasumura Mouse mutant deficient in d-amino acid oxidase activity Genetics 103 1983 277 285 (Pubitemid 13147202)
26. J.H. Krystal, L.P. Karpe, J.P. Seibly, G.K. Freeman, R. Delaney, and J.D. Bremner Subanesthetic effects of noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch. Gen. Psychiatry 51 1994 199 214 (Pubitemid 24081509)
27. C. Madeira, M.E. Freitas, C. Vargas-Lopes, H. Wolosker, and R. Panizzutti Increased brain d-amino acid oxidase (DAAO) activity in schizophrenia Schizophr. Res. 101 2008 76 83
28. M. Maekawa, M. Watanabe, S. Yamaguchi, R. Konno, and Y. Hori Spatial learning and long-term potentiation of mutant mice lacking d-amino-acid oxidase Neurosci. Res. 53 2005 34 38 (Pubitemid 41073725)
29. H. Matsuo, Y. Kanai, M. Tokunaga, T. Nakata, A. Chairoungdua, H. Ishimine, S. Tsukada, H. Ooigawa, H. Nawashiro, Y. Kobayashi, J. Fukuda, and H. Endou High affinity d- and l-serine transporter Asc-1: cloning and dendritic localization in the rat cerebral and cerebellar cortices Neurosci. Lett. 358 2004 123 126 (Pubitemid 38340736)
30. C.J. Mcbain, N.W. Kleckner, S. Wyrick, and R. Dingledine Structural requirements for activation of the glycine coagonist site of N-methyl-d-aspartate receptors expressed in xenopus oocytes Mol. Pharmacol. 36 1989 556 565 (Pubitemid 19273831)
31. S. Moreno, R. Nardacci, A. Cimini, and M.P. Ceru Immunocytochemical localization of d-amino acid oxidase in rat brain J. Neurocytol. 28 1999 169 185 (Pubitemid 30123547)
32. J.-P. Mothet, A.T. Parent, H. Wolosker, R.O. Brady Jr., D.J. Linden, C.D. Ferris, M.A. Rogawski, and S.H. Snyder d-Serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor Proc. Natl. Acad. Sci. U. S. A. 97 2000 4926 4931 (Pubitemid 30238659)
33. National Research Council Guide for the Care and Use of Laboratory Animals 1996 National Academy Press Washington, D.C.
34. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates second ed. 1986 Academic Press New York, NY
35. U. Rutishauser, B. Ross, A.N. Mamelak, and E.M. Schuman Human memory strength is predicted by theta-frequency phase-locking of single neurons Nature 464 2010 903 907
36. M.J. Schell, R.O. Brady Jr., M.E. Molliver, and S.H. Snyder d-serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors J. Neurosci. 17 1997 1604 1615 (Pubitemid 27089806)
37. J. Shi, E.S. Gershon, and C. Liu Genetic associations with schizophrenia: meta analyses of 12 candidate genes Schizophr. Res. 104 2008 96 107
38. C.J. Siok, J.A. Rogers, B. Kocsis, and M. Hajós Activation of alpha7 acetylcholine receptors augments stimulation-induced hippocampal theta oscillations Eur. J. Neurosci. 23 2006 570 574
39. S.M. Smith, J.M. Uslaner, L. Yao, C.M. Mullins, N.O. Surles, S.L. Huszar, C.H. McNaughton, D.M. Pascarella, M. Kandebo, R.M. Hinchliffe, T. Sparey, N.J. Brandon, B. Jones, S. Venkatraman, M.B. Young, N. Sachs, M.A. Jacobson, and P.H. Hutson The behavioral and neurochemical effects of a novel d-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and d-serine J. Pharmacol. Exp. Ther. 328 2009 921 930
40. T. Sparey, P. Abeywickrema, S. Almond, N. Brandon, N. Byrne, A. Campbell, P.H. Hutson, M. Jacobson, B. Jones, S. Munshi, D. Pascarella, A. Pike, G.S. Prasad, N. Sachs, M. Sakatis, V. Sardana, S. Venkatraman, and M.B. Young The discovery of fused pyrrole carboxylic acids as novel, potent d-amino acid oxidase (DAAO) inhibitors Bioorg. Med. Chem. Lett. 18 2008 3386 3391 (Pubitemid 351718313)
41. G.E. Tsai, and P.-Y. Lin Strategies to enhance N-Methyl-d-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis Curr. Pharm. Design 16 2010 522 537
42. L. Verrall, M. Walker, N. Rawlings, I. Benzel, J.N.C. Kew, P.J. Harrison, and P.W.J. Burnet d-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia Eur. J. Neurosci. 26 2007 1657 1669 (Pubitemid 47416520)
43. R.P. Vertes Brain stem generation of the hippocampal EEG Prog. Neurobiol. 19 1982 159 186
44. H. Wolosker, K.N. Sheth, M. Takahashi, J.-P. Mothet, R.O. Brady Jr., C.D. Ferris, and S.H. Snyder Purification of serine racemase: biosynthesis of the neuromodulator d-serine Proc. Natl. Acad. Sci. U. S. A. 96 1999 721 725 (Pubitemid 29061275)
45. P.L. Wood, T.S. Rao, S. Iyengar, T. Lanthorn, J. Monahan, A. Cordi, E. Sun, M. Vazquez, N. Gray, and P. Contreras A review of the in vitro and in vivo neurochemical characterization of the NMDA/PCP/glycine/ion channel receptor macrocomplex Neurochem. Res. 15 1990 217 230 (Pubitemid 20102163)
46. K. Yamada, T. Ohnishi, K. Hashimoto, H. Ohba, Y. Iwayama-Shigeno, M. Toyoshima, A. Okuno, H. Takao, T. Toyota, Y. Minabe, K. Nakamura, E. Shimizu, M. Itokawa, N. Mori, M. Iyo, and T. Yoshikawa Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and d-serine levels Biol. Psychiatry 57 2005 1493 1503 (Pubitemid 40805378)